NYSE:MDHealthcare
How Strong Quarterly Results But Softer Long-Term Returns At Pediatrix (MD) Have Changed Its Investment Story
Pediatrix Medical Group recently reported strong quarterly results that were well received, even as its long-term revenue growth has averaged just 2.1% annually over the past five years and its return on invested capital has moved lower.
This combination of solid near-term performance and weaker long-term growth metrics highlights a tension between current operating strength and questions about the company’s future expansion prospects.
Next, we’ll examine how the solid quarterly performance...